Statin use associated with increased risk of prostate cancer

This study was published in Prostate Cancer and Prostatic Diseases 2005;8(4):316-20

Study title and authors:
Hypertriglyceridemia as a possible risk factor for prostate cancer.

Wuermli L, Joerger M, Henz S, Schmid HP, Riesen WF, Thomas G, Krek W, Cerny T, Gillessen S.
Department of Internal Medicine, Kantonsspital St.Gallen, Switzerland.

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/16158078

This study assessed various factors in patients with prostate cancer and compared them with patients with benign prostatic hyperplasia. (Benign prostatic hyperplasia is an increase in size of the prostate gland without malignancy present and it is so common as to be normal with advancing age). The study included 504 patients diagnosed with prostate cancer and 565 age-matched patients with benign prostatic hyperplasia.

Regarding statins, the study found that statin usage was 23% higher in the patients that had developed prostate cancer compared to the patients with an enlarged prostate.